A dimensional approach to psychosis: identifying cognition, depression, and thought disorder factors in a clinical sample

Traditional classification systems based on broad nosological categories do not adequately capture the high heterogeneity of mental illness. One possible solution to this is to move to a multi-dimensional model of mental illness, as has been proposed by the Research Domain Criteria and Hierarchical Taxonomy of Psychopathology frameworks. In this study, we explored the dimensional structure of psychotic disorders. We focused on the question whether combining measures of psychosis with cognitive and depression-related measures results in meaningful, clinically relevant, and valid latent dimensions in a sample of early psychosis (n = 113) and chronic schizophrenia patients (n = 43, total n = 156). We used exploratory factor analysis to identify the symptom dimensions in the Lausanne Psychosis data, a multi-modal prospective data set that includes a broad behavioral assessment of patients diagnosed with psychotic disorders. We evaluated the validity of these dimensions by regressing them to several functioning measures. Our analysis revealed three dimensions: Cognition, Depression/Negative, and Thought Disorder, explaining 49.2% of the variance. They were related to measures of functioning, the R² ranging between 0.38 and 0.42. This study advances the development of a multi-dimensional characterization of psychotic disorders by identifying three symptom dimensions with predictive validity in people with psychosis.

Authors

Institutions

Publication Details

Journal
Schizophrenia
Published
2025-07-14
DOI
https://doi.org/10.1038/s41537-025-00641-x
Citations
1
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
1.47

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A dimensional approach to psychosis: identifying cognition, depression, and thought disorder factors in a clinical sample

Raoul Jenni, Philippe Conus, Luis Alameda, Paul Klauser et al.
1 citations
Schizophrenia
Schizophrenia research and treatment
1.47
article

A dimensional approach to psychosis: identifying cognition, depression, and thought disorder factors in a clinical sample

Raoul Jenni, Philippe Conus, Luis Alameda, Paul Klauser, Thomas A. W. Bolton, Philippe Golay, Jagruti Patel, Andrea Mechelli, Patric Hagmann, Mikkel Schöttner Sieler
article en
1 citations

Abstract

Traditional classification systems based on broad nosological categories do not adequately capture the high heterogeneity of mental illness. One possible solution to this is to move to a multi-dimensional model of mental illness, as has been proposed by the Research Domain Criteria and Hierarchical Taxonomy of Psychopathology frameworks. In this study, we explored the dimensional structure of psychotic disorders. We focused on the question whether combining measures of psychosis with cognitive and depression-related measures results in meaningful, clinically relevant, and valid latent dimensions in a sample of early psychosis (n = 113) and chronic schizophrenia patients (n = 43, total n = 156). We used exploratory factor analysis to identify the symptom dimensions in the Lausanne Psychosis data, a multi-modal prospective data set that includes a broad behavioral assessment of patients diagnosed with psychotic disorders. We evaluated the validity of these dimensions by regressing them to several functioning measures. Our analysis revealed three dimensions: Cognition, Depression/Negative, and Thought Disorder, explaining 49.2% of the variance. They were related to measures of functioning, the R² ranging between 0.38 and 0.42. This study advances the development of a multi-dimensional characterization of psychotic disorders by identifying three symptom dimensions with predictive validity in people with psychosis.

SchizophreniaVol. 11(1)
King's College London (GB), Instituto de Biomedicina de Sevilla (ES), Hospital Universitario Virgen del Rocío (ES), University of Lausanne (CH)
National Science Foundation, Wellcome, Wellcome Trust, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Good health and well-being
Openalex Percentile: Top 17%
Schizophrenia research and treatment
1.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.